Total AUM for Bajaj Finance grew 35% year-over-year, driven by strong loan growth and customer acquisition.
Bajajfinsv Ltd — Q3 FY24
Bajaj Finserv reported a strong Q3 FY24 with consolidated total income up 34% to INR 29,038 crore and PAT up 21% to INR 2,158 crore.
✓ Verified against BSE filing
2-Minute Summary
Bajaj Finserv reported a strong Q3 FY24 with consolidated total income up 34% to INR 29,038 crore and PAT up 21% to INR 2,158 crore. Growth was driven by robust performance across subsidiaries: Bajaj Finance (AUM +35%, PAT +22%), Bajaj Allianz General Insurance (GDPI +18.7% despite Nat Cat impact), and Bajaj Allianz Life Insurance (IRNB +24%, NBV +19%). The company announced the acquisition of Vidal Healthcare for INR 325 crore to strengthen its healthcare payment ecosystem. Management expressed confidence in sustained growth, citing favorable macro conditions and strategic investments. Key risks include potential regulatory changes on life insurance surrender norms and competitive pressure in motor insurance.
बजाज फिनसर्व ने तीसरी तिमाही में शानदार प्रदर्शन किया। कंपनी की कुल आय 34% बढ़कर 29,038 करोड़ रुपये और मुनाफा 21% बढ़कर 2,158 करोड़ रुपये हुआ। इसकी मुख्य कंपनियों ने अच्छा काम किया - बजाज फाइनेंस का कर्ज पोर्टफोलियो 35% और मुनाफा 22% बढ़ा। बीमा कंपनियों ने भी अच्छी कमाई की। कंपनी ने स्वास्थ्य सेवा के भुगतान को बेहतर बनाने के लिए विडाल हेल्थकेयर को 325 करोड़ रुपये में खरीदा। प्रबंधन का कहना है कि अर्थव्यवस्था मजबूत है और निवेश से आगे भी अच्छा प्रदर्शन होगा। लेकिन बीमा नियमों में बदलाव और मोटर बीमा में प्रतिस्पर्धा से सावधान रहना होगा।
Key Numbers
Individual rated new business premium grew 24% YoY, highest among top 10 private players.
Excluding natural catastrophe losses, combined ratio improved to 99.5% from 100.3% last year.
Highest ever quarterly customer additions at 38.5 lakh, taking total franchise to 8.04 crore.
What Changed vs Last Quarter
Management expects continued strong growth in IRNB, with focus on product mix and channel diversification.
The company aims to grow faster than the industry in profitable segments, leveraging distribution expansion.
The acquisition of Vidal Healthcare will accelerate Finserv Health's position in the healthcare payment spectrum.
Deficiencies pointed out by RBI have been mostly cleared; disbursements expected to resume after regulatory approval.
Due to investments in manpower and rural expansion, combined ratio may temporarily exceed 100% before normalizing.
Management expects NBV growth to sustain as par product mix improves and new bank partnerships contribute.
BFL continues to deliver on AUM growth, profitability, and asset quality targets as per its stated guidance.
Proposed IRDAI changes to surrender values could impact product profitability and persistency.
Motor insurance growth slowed to 5% due to competitive pricing and conservative underwriting stance.
Banks may prioritize deposits over third-party products, pressuring bancassurance growth.
Frequent Nat Cat events increased combined ratio to 102.9% in Q3; core profitability remains strong.
The Gujarat government health scheme may have higher loss ratios due to backlog claims, though 80% is reinsured.
BAGIC's expense ratio may rise as investments in manpower and rural branches continue, impacting near-term profitability.
Analyst raised concern about sustainability of crop and government health business given competitive pricing and tender-based nature.
Higher share of lower-margin products (ULIP, non-par) and investments in new channels may keep VNB margins below prior year levels.
🤫 Topics management stopped discussing
Mentioned in Q1 FY24, Q2 FY24
Management expects NBV growth to sustain as par product mix improves and new bank partnerships contribute.
Mentioned in Q1 FY24, Q2 FY24
Analyst raised concern about sustainability of crop and government health business given competitive pricing and tender-based nature.
Management Guidance
Bajaj Allianz Life to maintain market-leading growth
Management expects continued strong growth in IRNB, with focus on product mix and channel diversification.
Management guidance growthBajaj Allianz General to sustain above-industry growth
The company aims to grow faster than the industry in profitable segments, leveraging distribution expansion.
Management guidance growthBajaj Finserv Health to scale via Vidal acquisition
The acquisition of Vidal Healthcare will accelerate Finserv Health's position in the healthcare payment spectrum.
Management guidance expansionBajaj Finance to resume digital card issuance soon
Deficiencies pointed out by RBI have been mostly cleared; disbursements expected to resume after regulatory approval.
Management guidance otherKey Risks
Regulatory risk on life insurance surrender norms
Proposed IRDAI changes to surrender values could impact product profitability and persistency.
medium · analyst_questionIntense competition in motor insurance
Motor insurance growth slowed to 5% due to competitive pricing and conservative underwriting stance.
medium · analyst_questionDependence on bank insurance partners
Banks may prioritize deposits over third-party products, pressuring bancassurance growth.
medium · analyst_questionNatural catastrophe claims impact
Frequent Nat Cat events increased combined ratio to 102.9% in Q3; core profitability remains strong.
low · management_commentaryNotable Quotes
We are obsessed about customers, innovate, bring in new innovation to the market, look at all segments of businesses, and ensure that we have healthy growth, and we also take care of our bottom line and solvency.
We intend to not being lopsided in any one relationship. I think that's been a strategic decision that we have taken, which is why we actively go ahead and sort out new bank partners, and our agency channels and our direct channels have been fast growing.
With acquisition of Vidal, we get access to healthcare spends in hospitalization. As I told, it is the largest spend pool in healthcare ecosystem at this point of time in India.
Frequently Asked Questions
What was Bajajfinsv's revenue in Q3 FY24?
Bajajfinsv reported revenue of ₹29,038 Cr in Q3 FY24, representing a +34% change compared to the same quarter last year.
What guidance did Bajajfinsv management give for FY25?
Bajaj Allianz Life to maintain market-leading growth: Management expects continued strong growth in IRNB, with focus on product mix and channel diversification. Bajaj Allianz General to sustain above-industry growth: The company aims to grow faster than the industry in profitable segments, leveraging distribution expansion. Bajaj Finserv Health to scale via Vidal acquisition: The acquisition of Vidal Healthcare will accelerate Finserv Health's position in the healthcare payment spectrum. Bajaj Finance to resume digital card issuance soon: Deficiencies pointed out by RBI have been mostly cleared; disbursements expected to resume after regulatory approval.
What are the key risks for Bajajfinsv in FY25?
Key risks include Regulatory risk on life insurance surrender norms — Proposed IRDAI changes to surrender values could impact product profitability and persistency.; Intense competition in motor insurance — Motor insurance growth slowed to 5% due to competitive pricing and conservative underwriting stance.; Dependence on bank insurance partners — Banks may prioritize deposits over third-party products, pressuring bancassurance growth.; Natural catastrophe claims impact — Frequent Nat Cat events increased combined ratio to 102.9% in Q3; core profitability remains strong..
Did Bajajfinsv meet its previous quarter's guidance?
Of 3 tracked promises, management 0 met, 0 close, 3 missed.
Where can I read the full Bajajfinsv Q3 FY24 concall transcript?
The full earnings conference call transcript or source release is available on the linked source material. This page provides an AI-generated summary with filing verification status shown on the financial stats.